Peptech name change to Arana Therapeutics
Peptech has announced an official name change to Arana Therapeutics. The company’s ASX code will change to AAH this week and its code on the London Stock Exchange has been changed to AAHx.
Arana Therapeutics, created by the merger of Peptech and EvoGenix in August 2007, is focused on developing antibody/protein-based new generation products and platforms for the treatment of inflammatory diseases and cancer.
“This final step in the merger of Peptech and EvoGenix creates a true global player in the antibody therapeutics sector,” said Robin Beaumont, chairman of Arana Therapeutics.
“As well as critical mass, Arana Therapeutics has the right mix of people, skills, technologies and, most importantly, financial backing to achieve international recognition. Our key focus now is to rapidly develop our exciting product pipeline.”
Director of scientific R&D firm fined $195K+ over biogas experiments
The fine follows a 2022 incident in which a doctor sustained serious injuries after exposure to...
7th edition of STEM Equity Monitor now available
The latest national data resource on diversity in STEM has new design features intended to...
Professor Girish Dwivedi wins 2026 WA Pearcey Entrepreneur of the Year Award
As part of the 35th annual WAITTA INCITE Awards, Dwivedi was recognised for his contribution to...
